Recent News

• 08.27.2025 - Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
• 08.27.2025 - Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
• 08.25.2025 - Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
• 08.25.2025 - Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
• 08.05.2025 - Axogen, Inc. Reports Second Quarter 2025 Financial Results
• 08.05.2025 - Axogen, Inc. Reports Second Quarter 2025 Financial Results
• 07.29.2025 - Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
• 07.29.2025 - Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
• 07.22.2025 - Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
• 07.22.2025 - Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025

Recent Filings

• 08.25.2025 - 8-K Current report
• 08.25.2025 - EX-99.1 EX-99.1
• 08.05.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.05.2025 - 8-K Current report
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - EX-99.1 EX-99.1
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities